Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at QUEST DIAGNOSTICS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. QUEST DIAGNOSTICS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. QUEST DIAGNOSTICS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Michael E. Prevoznik
Senior Vice President and General Counsel
Total Cash $1,022,796 Equity $1,366,584 Other $53,920 Total Compensation $2,443,300
Stephen H. Rusckowski
Former Chairman, Chief Executive Officer and President
Total Cash $4,135,532 Equity $11,225,463 Other $317,168 Total Compensation $15,678,163
Catherine T. Doherty
Senior Vice President, Regional Businesses
Total Cash $1,174,731 Equity $1,659,425 Other $39,154 Total Compensation $2,873,310
Mark J. Guinan
Former Executive Vice President and Chief Financial Officer
Total Cash $843,324 Equity $1,636,172 Other $61,913 Total Compensation $2,541,409
James E. Davis
Chairman, Chief Executive Officer and President
Total Cash $1,888,622 Equity $9,792,392 Other $202,012 Total Compensation $11,883,026
Carrie Eglinton Manner
Former Senior Vice President, Advanced and General Diagnostics and Clinical Solutions
Total Cash $270,673 Equity $3,892,500 Other $48,358 Total Compensation $4,211,531
Patrick Plewman
Senior Vice President, Diagnostic Services
Total Cash $953,380 Equity $977,985 Other $48,579 Total Compensation $1,979,944
Sam A. Samad
Executive Vice President and Chief Financial Officer
Total Cash $2,225,693 Equity $3,955,771 Other $87,518 Total Compensation $6,268,982
For its 2022 fiscal year, QUEST DIAGNOSTICS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
James E. Davis CEO Pay $11,903,795 Median Employee Pay $63,854 CEO Pay Ratio 186:1
For its 2022 fiscal year, QUEST DIAGNOSTICS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Denise M. Morrison Total Cash $296,943
Gail R. Wilensky Total Cash $317,943
Gary M. Pfeiffer Total Cash $339,443
Helen I. Torley Total Cash $58,500
Timothy L. Main Total Cash $315,443
Timothy M. Ring Total Cash $345,943
Tracey C. Doi Total Cash $300,443
Vicky B. Gregg Total Cash $314,443
Wright L. Lassiter, III Total Cash $300,443

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.